Kim, Byung-Kun
Chu, Min Kyung
Yu, Soo Jin
Dell’Agnello, Grazia
Han, Jeong Hee
Cho, Soo-Jin http://orcid.org/0000-0002-4053-3763
Funding for this research was provided by:
Eli Lilly and Company
Korean Headache Society
Article History
Received: 29 October 2020
Accepted: 29 April 2021
First Online: 24 May 2021
Change Date: 11 June 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s10194-021-01270-2
Declarations
:
: Participants were recruited by their neurologists. Conducting of surveys is subject to Institutional Review Board exemption in Korea, but approval is required for preparation of a publication. Prior to participation, patients provided written consent to use the results of the survey for statistical purposes. Approval for preparation of this manuscript was granted by the Institutional Review Board of Nowon Eulji Medical Center (Approval No 2020–06-009). Survey data were handled confidentially, and anonymity of respondents was maintained throughout the study.
: Not applicable.
: BKK has received consulting fees and honoraria from the Center for New Health Technology Assessment, National Pension Service, Eli Lilly, Allergan, Teva, Lundbeck, Novartis, Sanofi Korea, SK Pharm, Yuyu Pharm, and Ildong Pharm during the last two years. MKC was involved as a site investigator for a multicenter trial sponsored by Otsuka Korea, Allergan, Ildong Pharmaceutical Co., LTD, Novartis International AG, and Eli Lilly and Company. He has worked as an advisory member for Teva, and has received lecture honoraria from Allergan Korea, Handok-Teva and Yuyu Pharmaceutical Company. SJY is a full-time employee of Eli Lilly and Company. GDA is a full-time employee and a minor stockholder of Eli Lilly and Company. JHH is a full-time employee of Eli Lilly and Company. SJC was involved as a site investigator for a multicenter trial sponsored by Otsuka Korea, Allergan, Ildong Pharmaceutical Co., LTD, Novartis International AG, Eli Lilly and Company, Parexel Korea Co., Ltd., and has received lecture honoraria from Allergan Korea, WhanIn Pharm Co., LTD, Handok-Teva, Yuyu Pharmaceutical Company, and SK Chemicals.